Novo Nordisk Wegovy Trial Drives 4.2% Stock Surge
Can the Novo Nordisk Wegovy Trial strengthen its obesity lead just as Wall Street starts pricing in the next GLP-1 combination wave? Maik Kemper Editor in Chief Combination…
Arm Holdings Chip Selloff -4.5% Signals AI Valuation Risk
Is the Arm Holdings Chip Selloff just a temporary semiconductor wobble, or a warning that AI valuations have finally gone too far? Maik Kemper Editor in Chief Arm’s…
Medtronic Upgrade Sends Shares Up 5.1% After Q2 Beat
Is the Medtronic Upgrade the start of a bigger rerating, or just a brief earnings-fueled spike? Maik Kemper Editor in Chief Management’s execution in cardiovascular innovation — combined…
Rocket Lab Neutron +5.8% as SpaceX IPO Buzz Lifts RKLB
Can Rocket Lab Neutron turn SpaceX IPO excitement into a lasting breakout for RKLB investors? Maik Kemper Editor in Chief Neutron isn’t a concept—it’s a booked, funded, and…
ServiceNow AI Strategy +3%: AI Control Tower Drives Buzz
Can ServiceNow AI Strategy turn enterprise AI chaos into a new growth engine before Wall Street fully prices it in? Maik Kemper Editor in Chief No other SaaS…
Robinhood PDT Rule +5%: Why HOOD Is Soaring Now
Can the Robinhood PDT Rule shake-up turn small accounts into a lasting growth engine for HOOD? Maik Kemper Editor in Chief Eliminating the $25,000 PDT threshold removes an…
Goldman Sachs SpaceX IPO Drives GS Stock Up 4.95%
Can the Goldman Sachs SpaceX IPO turn one blockbuster deal into a broader rerating for GS shares? Maik Kemper Editor in Chief There’s plenty of liquidity in the…
American Express Delta Partnership Drives AXP 4.5% Surge
Can the American Express Delta Partnership turn richer travel perks into a lasting edge for AXP shares? Maik Kemper Editor in Chief This is what our partnership with…
Eli Lilly LillyDirect +5.4% as Weight Watchers Expands Access
Can Eli Lilly LillyDirect turn obesity drugs into a full-service care platform that rivals cannot easily copy? Maik Kemper Editor in Chief LillyDirect is becoming the de facto…
PVH Earnings Drop 21% as Outlook Cut Hits Shares Hard
Can PVH Earnings stabilize investor confidence after a brutal outlook cut, or is the EMEA slowdown only getting worse? Maik Kemper Editor in Chief For the first quarter,…